Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The key is to find a balance that works for you and consults with a healthcare professional for personalized advice
Usually worst during dose increases and improves as the body adjusts
These are typically dose-dependent and reversible with dose reduction or cycle discontinuation
Retatrutide Side Effects (Preliminary Data) Common (from Phase 2 data): Nausea (25-45% depending on dose) Diarrhea (20-35%) Vomiting (10-20%) Constipation (10-15%) Decreased appetite Notable differences: Mild increases in resting heart rate observed The glucagon receptor component may introduce metabolic effects not seen with GLP-1-only medications Full safety profile awaiting Phase 3 data The overall tolerability of retatrutide in the Phase 2 trial was described as acceptable, with most adverse events being mild to moderate
KEY FEATURES Retatrutide lyophilised research-grade peptide 10mg per vial Independent HPLC-MS verified to 99.79% purity (CoA on public Lab Results portal) Single-batch fill, single-batch chromatogram no blending across lots Synthesised in accredited contract laboratories with full QA paper trail Crimp-sealed, tamper-evident research vial in unbranded outer packaging Dispatched from Australia on Auspost Express with insulated cold-pack option SPECIFICATIONS Product Name Retatrutide Category Metabolic Research Peptides Grade Research grade laboratory use only Quantity 10mg per vial Form Lyophilised powder cake Purity 99.79% verified by HPLC-MS Appearance White to off-white lyophilised solid Storage 28 C lyophilised
The result is that you burn fewer calories at rest and you feel more tired
US$ 25.31
US$ 20.73
US$ 23.96
